Enwave Corporation Stock
€0.23
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Enwave Corporation | 0.890% | 5.556% | -6.557% | 79.528% | 65.217% | -38.378% | -55.985% |
Promis Neurosciences Inc. | -4.550% | 5.000% | -19.231% | -61.429% | -55.266% | -92.731% | -92.921% |
Resverlogix Corp | 7.890% | 6.957% | 11.818% | 73.239% | 127.778% | -58.446% | -91.214% |
Aurinia Pharmaceuticals Inc. | 1.270% | 1.652% | 5.829% | 71.334% | 26.803% | 46.166% | -12.520% |
News

EnWave Sells 120kW Radiant Energy Vacuum Machine to BranchOut Food, Grants Expanded Global Rights for Dragon Fruit
Vancouver, B.C., September 18th, 2025, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed an Equipment Purchase Agreement (the “EPA”)

EnWave Reports 2025 Third Quarter Consolidated Interim Financial Results
Vancouver, B.C., August 22nd, 2025. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the third

EnWave Corporation Announces Closing of Fully Subscribed $3 Million LIFE Offering
Not for distribution to United States newswire services or for dissemination in the United States
Vancouver, B.C., August 21st, 2025. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or